Enniatin B1CAS# 19914-20-6 |
2D Structure
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 19914-20-6 | SDF | Download SDF |
PubChem ID | 177097 | Appearance | Powder |
Formula | C34H59N3O9 | M.Wt | 653.9 |
Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 3-butan-2-yl-4,10,16-trimethyl-6,9,12,15,18-penta(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone | ||
SMILES | CCC(C)C1C(=O)OC(C(=O)N(C(C(=O)OC(C(=O)N(C(C(=O)OC(C(=O)N1C)C(C)C)C(C)C)C)C(C)C)C(C)C)C)C(C)C | ||
Standard InChIKey | UQCSETXJXJTMKO-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C34H59N3O9/c1-16-22(12)25-34(43)46-27(20(8)9)30(39)36(14)23(17(2)3)32(41)44-26(19(6)7)29(38)35(13)24(18(4)5)33(42)45-28(21(10)11)31(40)37(25)15/h17-28H,16H2,1-15H3 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Enniatin B1 has intestinal toxicity. 2. Enniatins A, A(1), B, B(1) have antifungal effects. 3. Enniatins A1, B and B1 induce apoptotic cell death in H4IIE hepatoma cells accompanied by inhibition of ERK phosphorylation. |
Targets | ERK | TNF-α | NF-kB | Antifection |
Enniatin B1 Dilution Calculator
Enniatin B1 Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.5293 mL | 7.6464 mL | 15.2929 mL | 30.5857 mL | 38.2321 mL |
5 mM | 0.3059 mL | 1.5293 mL | 3.0586 mL | 6.1171 mL | 7.6464 mL |
10 mM | 0.1529 mL | 0.7646 mL | 1.5293 mL | 3.0586 mL | 3.8232 mL |
50 mM | 0.0306 mL | 0.1529 mL | 0.3059 mL | 0.6117 mL | 0.7646 mL |
100 mM | 0.0153 mL | 0.0765 mL | 0.1529 mL | 0.3059 mL | 0.3823 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Futoenone
Catalog No.:BCN6408
CAS No.:19913-01-0
- Chamigrenal
Catalog No.:BCN7847
CAS No.:19912-84-6
- Furanodiene
Catalog No.:BCN6454
CAS No.:19912-61-9
- T 98475
Catalog No.:BCC7395
CAS No.:199119-18-1
- Balaglitazone
Catalog No.:BCC1395
CAS No.:199113-98-9
- H-Phe(4-Me)-OH
Catalog No.:BCC3270
CAS No.:1991-87-3
- Maackiain
Catalog No.:BCN1236
CAS No.:19908-48-6
- Bakkenolide A
Catalog No.:BCN5402
CAS No.:19906-72-0
- Dihydromethysticin
Catalog No.:BCN2476
CAS No.:19902-91-1
- Syringaresinol diacetate
Catalog No.:BCN4874
CAS No.:1990-77-8
- Kaempferol 3-O-beta-sophoroside
Catalog No.:BCN3336
CAS No.:19895-95-5
- 29-Nor-20-oxolupeol
Catalog No.:BCN6678
CAS No.:19891-85-1
- Boc-D-N-Me-Ala-OH
Catalog No.:BCC3211
CAS No.:19914-38-6
- O6-Benzylguanine
Catalog No.:BCC6485
CAS No.:19916-73-5
- Dehydroglyasperin C
Catalog No.:BCN6790
CAS No.:199331-35-6
- Glyurallin A
Catalog No.:BCN7538
CAS No.:199331-36-7
- Crocatone
Catalog No.:BCN3532
CAS No.:19937-86-1
- Kolavenol
Catalog No.:BCN4680
CAS No.:19941-83-4
- Gymnestrogenin
Catalog No.:BCN7846
CAS No.:19942-02-0
- 3-Epicabraleadiol
Catalog No.:BCN4875
CAS No.:19942-04-2
- Y-33075
Catalog No.:BCC2064
CAS No.:199433-58-4
- Veraguensin
Catalog No.:BCN2163
CAS No.:19950-55-1
- 2-Amino-4-chlorobenzothiazole
Catalog No.:BCC8529
CAS No.:19952-47-7
- NNC 26-9100
Catalog No.:BCC7361
CAS No.:199522-35-5
Antifungal effects of the bioactive compounds enniatins A, A(1), B, B(1).[Pubmed:20417654]
Toxicon. 2010 Sep 1;56(3):480-5.
To produce enniatin (ENs), Fusarium tricinctum CECT 20150 was grown in a liquid medium of potato (PDB), being mycotoxin purified by high performance liquid chromatography (HPLC) with a reverse phase semipreparative column using a mobile phase of acetonitrile/water using gradient condition. The purity of the ENs fractions was verified by analytical HPLC and LC/MS-MS. The pure fractions of ENs were utilized to study the biological activity on several mycotoxigenic moulds as Fusarium verticilloides, Fusarium sporotrichioides, Fusarium tricinctum, Fusarium poae, Fusarium oxysporum, Fusarium proliferatum, Beauveria bassiana, Trichoderma harzianum, Aspergillus flavus, Aspergillus parasiticus, Aspergillus fumigatus, Aspergillus ochraceus and Penicillium expansum. The results obtained demonstrated that in several antibiograms, ENs induced the inhibition of the grown microorganisms tested.
Pilot toxicokinetic study and absolute oral bioavailability of the Fusarium mycotoxin enniatin B1 in pigs.[Pubmed:24239892]
Food Chem Toxicol. 2014 Jan;63:161-5.
The aim of present study was to reveal the toxicokinetic properties and absolute oral bioavailability of Enniatin B1 in pigs. Five pigs were administered this Fusarium mycotoxin per os and intravenously in a two-way cross-over design. The toxicokinetic profile fitted a two-compartmental model. Enniatin B1 is rapidly absorbed after oral administration (T(1/2a)=0.15 h, Tmax=0.24h) and rapidly distributed and eliminated as well (T(1/2elalpha)=0.15 h; T(1/2elbeta)=1.57 h). The absolute oral bioavailability is high (90.9%), indicating a clear systemic exposure. After intravenous administration, the mycotoxin is distributed and eliminated rapidly (T(1/2elalpha)=0.15 h; T(1/2elbeta)=1.13 h), in accordance with oral administration.
The emerging mycotoxin, enniatin B1, down-modulates the gastrointestinal toxicity of T-2 toxin in vitro on intestinal epithelial cells and ex vivo on intestinal explants.[Pubmed:23649843]
Arch Toxicol. 2013 Dec;87(12):2233-41.
Enniatins, the most prevalent emerging mycotoxins, represent an emerging food safety issue, because of their common co-occurrence with other fusariotoxins such as trichothecenes co-produced by Fusarium spp on field grains and because of their extensive prevalence in grains. In this study, the intestinal toxicity of Enniatin B1 (ENN) alone and mixed with the most toxic trichothecene T-2 toxin (T2) was characterized by using two biological models from pig, the most sensitive species: the intestinal cell line IPEC1 (in vitro exposure) and jejunal explants (ex vivo exposure). Dose-dependent decreases in cell proliferation in IPEC1 and in the histopathological scores of explants were observed for ENN at muM-levels and for T2 at nM-levels, with IC50 values for ENN of 15.8 and 29.7 muM, and for T2 of 9.3 and 15.1 nM in vitro and ex vivo, respectively. Interaction analysis by probabilistic and by determinist approaches showed a less than additive effect both in vitro and ex vivo, at IC50 values, with increasing antagonism with decreasing concentrations of toxins. The results obtained by the determinist median-effect dose analysis and by the nonlinear regression analysis were concordant. All the median-effect doses estimated for IPEC cells were included in the IC50 confidence intervals of the nonlinear regression fitting. Given the occurrence of enniatins, potential synergy following the co-occurrence of enniatins and the major fusariotoxins, especially trichothecene B deoxynivalenol should be investigated.
Enniatins A1, B and B1 from an endophytic strain of Fusarium tricinctum induce apoptotic cell death in H4IIE hepatoma cells accompanied by inhibition of ERK phosphorylation.[Pubmed:19065580]
Mol Nutr Food Res. 2009 Apr;53(4):431-40.
Enniatins are mycotoxins which have important impact on human health, e.g. as contaminants of cereals, but also are discussed as possible anticancer agents. We investigated toxic effects of enniatins A1, B and B1 isolated from Fusarium tricinctum on different cancer cell lines. The enniatins showed moderate activity in HepG2 and C6 cells (EC(50)-values approximately 10-25 microM), but were highly toxic in H4IIE cells (EC(50)-values approximately 1-2.5 microM). In H4IIE cells, all enniatins increased caspase 3/7 activity and nuclear fragmentation as markers for apoptotic cell death. Enniatin A1, Enniatin B1, and, to a lesser extent, also enniatin B decreased the activation of extracellular regulated protein kinase (ERK) (p44/p42), a mitogen-activated protein kinase which is associated with cell proliferation. Furthermore, enniatins A1 and B1, but not enniatin B were able to inhibit moderately tumor necrosis factor alpha (TNF-alpha)-induced NF-kappaB activation. Screening of 24 additional protein kinases involved in signal transduction pathways (cell proliferation, survival, angiogenesis and metastasis) showed no inhibitory activity of enniatins. We conclude that enniatins A1 and B1 and, to a lesser extent, enniatin B may possess anticarcinogenic properties by induction of apoptosis and disruption of ERK signalling pathway. Further analysis of these substances is necessary to analyse their usefulness for cancer therapy.